
UTI Stock Forecast & Price Target
UTI Analyst Ratings
Bulls say
Universal Technical Institute Inc. has demonstrated strong financial performance, with annual revenue increasing by 19.3% year-over-year to $293.8 million, driven by robust enrollment and demand for its educational programs. The company's strategic marketing and admissions investments have resulted in an 8.1% growth in average student population, which, combined with a revenue per head increase of 2.5%, reflects a positive trend in operational efficiency. Additionally, adjusted EBITDA surged by 49.6% to $12.4 million, highlighting the effectiveness of margin expansion efforts across its segments, particularly within the Concorde business, which achieved an 18.2% revenue increase.
Bears say
Universal Technical Institute Inc. has shown stagnant growth with diluted earnings per share remaining flat year-over-year at $0.34, which was better than estimates but reflects a lack of significant performance improvement. Additionally, the adjusted EBITDA saw a decline of 1.4%, coupled with a further 8.6% drop to $34.2 million, indicating challenges in maintaining profitability margins. Furthermore, a notable 10.1% reduction in free cash flow and a mixed initial guidance for FY/26, despite some revenue growth, contributed to a sharp decline in stock price, signaling investor concerns about the company's future financial health.
This aggregate rating is based on analysts' research of Universal Technical Institute and is not a guaranteed prediction by Public.com or investment advice.
UTI Analyst Forecast & Price Prediction
Start investing in UTI
Order type
Buy in
Order amount
Est. shares
0 shares